Takeda to introduce new drug in U.S. for 1st time in 6 years

Takeda to introduce new drug in U.S. for 1st time in 6 years

OSAKA, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa speaks at a press conference in Tokyo on July 11. He said the company will start marketing a sleeping pill in the United States possibly in September, introducing the first drug into the U.S. market in six years. The insomnia pill, to be marketed as Rozerem, targets only the part of the brain that regulates sleep. In addition, it induces a state very similar to natural sleep, the company said.

  • Product Code
  • ILEA001109992
  • Registered date
  • 2005/7/11 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2005 Kyodo News
  • Media size
  • 1864 × 1228 pixel
  • Resolution
  • dpi
  • Deployment size
  • 452.76(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

        Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
          Honda's group net profit down for 1st time in 3 yrs

          Honda's group net profit down for 1st time in 3 yrs

          TOKYO, April 28 Kyodo - Tetsuo Iwamura, executive vice president of Honda Motor Co., announces the company's earnings results for the year ended in March 2015 at a press conference in Tokyo on April 28, 2015. Honda's group net profit fell for the first time in three years, down 8.9 percent from a year earlier to 522.76 billion yen ($4.4 billion), hurt by recall-related costs and sluggish sales in Japan.
            Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

            Otsuka to buy U.S. biopharmaceutical firm Avanir for $3.5 bil.

            TOKYO, Japan - Tatsuo Higuchi, president of Otsuka Holdings Co., attends a press conference in Tokyo's Minato Ward on Dec. 2, 2014, on the planned acquisition by its subsidiary Otsuka Pharmaceutical Co. of California-based biopharmaceutical firm Avanir Pharmaceuticals Inc. for $3.54 billion through a tender offer to be followed by a merger. The Japanese nutrition product and drug manufacturer will pay $17 per Avanir share in the takeover bid through its U.S. subsidiary.
              Skylark relisted on TSE after 8-yr hiatus

              Skylark relisted on TSE after 8-yr hiatus

              TOKYO, Japan - Skylark Co. President Makoto Tani (L) holds a press conference at the Tokyo Stock Exchange on Oct. 9, 2014. The restaurant chain operator was relisted in the TSE's first section for the first time in eight years after its delisting in 2006.
                TEPCO logs 1st pretax profit in 4 yrs for April-June qtr.

                TEPCO logs 1st pretax profit in 4 yrs for April-June qtr.

                TOKYO, Japan - Tokyo Electric Power Co. President Naomi Hirose announces the company's earnings report for the April-June quarter on July 31, 2014, in Tokyo, Japan. TEPCO turned to the black on a group pretax basis in the reporting period for the first time in the four years since the 2011 nuclear crisis at its Fukushima Daiichi power plant.
                  Panasonic returns to black

                  Panasonic returns to black

                  TOKYO, Japan - Panasonic Corp. President Kazuhiro Tsuga holds a press conference in Tokyo on April 28, 2014, when the company reported it returned to the black for the first time in three years. For the past business year to March 31, Panasonic posted a group net profit of 120.44 billion yen, the result of restructuring and increased sales by its housing and auto-related businesses.
                    Toyota ups FY 2013 profit outlook

                    Toyota ups FY 2013 profit outlook

                    TOKYO, Japan - Nobuyori Kodaira, executive vice president of Toyota Motor Corp., announces the company's earnings forecast at a press conference in Tokyo on Nov. 6, 2013. Kodaira said Toyota has revised upward its operating profit projection for the business year through March 2014 to 2.2 trillion yen, exceeding 2 trillion yen for the first time in six years.
                      Toyota ups FY 2013 profit outlook

                      Toyota ups FY 2013 profit outlook

                      TOKYO, Japan - Nobuyori Kodaira, executive vice president of Toyota Motor Corp., announces the company's earnings forecast at a press conference in Tokyo on Nov. 6, 2013. Kodaira said Toyota has revised upward its operating profit projection for the business year through March 2014 to 2.2 trillion yen, exceeding 2 trillion yen for the first time in six years.